Glick Gary D bought ODTX
May 11, 2026 · Form 4 insider transaction
Glick Gary D bought 27,386 shares of Odyssey Therapeutics, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
27,386
Price
N/A
Total value
N/A
InsiderGlick Gary D
RoleOfficer, Director
SecurityCommon Stock
Transaction codeC: Conversion of a derivative
Transaction dateMay 11, 2026
Filing dateMay 11, 2026
Shares owned after415,973
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Series C Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration.; The Series D Preferred Stock converted into Common Stock immediately prior to the closing of the Issuer's initial public offering on a 1-for-9.7170 basis for no additional consideration.